Search

everythinglearnresearchcommunity

for

Search:↓

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

The issue included new and updated reviews on various health interventions, with significant findings on weight loss, psychological therapies, cancer treatment, and more.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The medication lopinavir-ritonavir may cause severe hair loss.

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.

People with HIV and low T cell counts have more hair and scalp problems.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Early diagnosis of hair tourniquet syndrome saved a baby's toe from being lost.

Pill organizers and cutters can help with taking medication regularly but may affect the medication's effectiveness and safety.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Platelet-rich plasma may have some benefits in dermatology, but there's not enough evidence to widely recommend its use.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

New microneedle method improves hair regrowth treatment delivery.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

Zidovudine may cause hair loss in advanced-stage HIV patients.

A 66-year-old woman with skin lesions and other symptoms improved after treatment for porphyria cutanea tarda.

Men with male pattern baldness have higher uric acid levels, which can decrease with finasteride treatment.

The book is a comprehensive and current guide on hair disorders, with minor flaws.

HIV can cause unusual and severe skin problems that are hard to treat.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

HIV patients in Korea often have skin diseases like fungal infections, folliculitis, and seborrheic dermatitis, which are less common with effective HIV treatment.

The issue discussed China's research contributions, systematic review improvements, and featured various medical studies and trials.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

The conclusion is that fat grafting is safe and effective but carries risks that need careful management.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.